Okeke Ogwulu, C., Williams, E., Chu, J., Devall, A., Beeson, L., Hardy, P., Cheed, V., Yongzhong, S., Jones, L., La Fontaine Papadopoulos, J., Bender‐Atik, R., Brewin, J., Hinshaw, K., Choudhary, M., Ahmed, A., Naftalin, J., Nunes, N., Oliver, A., Izzat, F., Bhatia, K., Hassan, I., Jeve, Y., Hamilton, J., Debs, S., Bottomley, C., Ross, J., Watkins, L., Underwood, M., Cheong, Y., Kumar, C., Gupta, P., Small, R., Pringle, S., Hodge, F., Shahid, A., Horne, A., Quenby, S., Gallos, I., Coomarasamy, A., & Roberts, T. (2021). cost‐effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial. BJOG, 128, 1534–1545. http://access.bl.uk/ark:/81055/vdc_100134875323.0x00001f